Sina Sender

8PUBLICATIONS
12CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 14, 2022
Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach.

Sina Sender, Ahmad Wael Sultan, Daniel Palmer

|Sep 23, 2022
Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines.

Yixuan Ma, Benjamin Schulz, Nares Trakooljul

|Apr 23, 2022
Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.

Yixuan Ma, Sina Sender, Anett Sekora

|Apr 23, 2022
The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.

Yixuan Ma, Sina Sender, Anett Sekora

|Feb 15, 2022
A Simple LC-MS/MS Method for the Quantification of PDA-66 in Human Plasma.

Rico Schwarz, Elisabeth R D Seiler, Sina Sender

|Dec 10, 2021
BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells.

Weibo Kong, Sina Sender, Leila Taher

Pageof 2

Frequent Collaborators

6 joint publications

Hugo Murua Escobar

3 joint publications

Frank Ulrich Weiss

3 joint publications

Dietmar Zechner

2 joint publications

Leila Taher